Genentech Presents Vabysmo Real-World Data at EURETINA
Genentech announced new data from the VOYAGER study evaluating the effectiveness, durability, and safety of Vabysmo (faricimab-svoa) in wet age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following r...